Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00TNC
|
||||
Former ID |
DNC001261
|
||||
Drug Name |
S-8510
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nootropic [ICD10:F00-F99] | Discontinued in Phase 2 | [545890] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H15N4O7P
|
||||
Canonical SMILES |
C1COCC2=C1N=CC3=NC(=C4C=CON4)N=C23.O.OP(=O)(O)O
|
||||
InChI |
1S/C12H10N4O2.H3O4P.H2O/c1-3-17-6-7-8(1)13-5-10-11(7)15-12(14-10)9-2-4-18-16-9;1-5(2,3)4;/h2,4-5,16H,1,3,6H2;(H3,1,2,3,4);1H2/b12-9-;;
|
||||
InChIKey |
AGKHWTCNQDGCGE-AGZDHKJJSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [551871] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
HTLV-I infection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.